Healthcare Economics & Policy

Highly concentrated markets in the commercial health insurance industry are on the rise, leaving millions more Americans with limited choices when it comes to getting coverage, according to the American Medical Association.

A whopping 40% of patients said the state of the economy affects how often they seek medical care, according to a recent TransUnion Healthcare survey. Further, a quarter of people said they felt prompted to use their existing insurance for treatment they may have been putting off when they heard news about a worsening economy.

Purdue Pharma, a drug manufacturer and maker of the popular opioid OxyContin, filed for bankruptcy in the fallout of thousands of lawsuits targeting the company for its role in the national opioid abuse and overdose epidemic.


Fresh off the heels of its announcement to enter primary care with its own clinic, retail giant Walmart is preparing a big push into the healthcare space.


The rate of uninsured Americans in 2018 rose for the first time since the Affordable Care Act went into place, according to new data from the Census Bureau.

Administering specialty drugs in physicians’ offices and patients’ homes instead of in-hospital could improve care and cut healthcare spending in the U.S. by $4 billion each year, according to a Sept. 9 report from UnitedHealth Group.

The reputation of the pharmaceutical industry is tanking among U.S. consumers, the latest Gallup poll reveals.

New gene therapies are carrying price tags in the millions, leaving insurers scrambling to figure out how to cover them and offer the treatments to enrollees, according to The Wall Street Journal.

U.S. District Court Judge Richard Leon has approved the $69 billion acquisition of Aetna by CVS Health, he announced in an opinion on Sept. 4.

Medicare Part D overpaid millions of dollars for prescription drugs that should have been covered by the Medicare Part A hospice benefit, according to a recent report from the Office of Inspector General (OIG), which conducted an audit from 2016 payments. In other words, CMS paid twice for the same drugs.

CVS Health announced a $2 million contribution to an existing $50 million campaign to end e-cigarette use, known as vaping, among teenagers. The announcement comes at a time when hundreds of lung disease injuries linked to vaping have appeared in dozens of states.

Purdue Pharma, the maker of popular opioid OxyContin, is preparing to file for bankruptcy before the end of September if the company doesn’t reach a settlement over thousands of lawsuits against the company for its role in the opioid abuse epidemic, Reuters reported, citing people familiar with the matter.